BiotechTube
Home/AlzeCure Pharma/Birgitta Lundvik
BL

Birgitta Lundvik

Chief Financial Officer (CFO)

AlzeCure Pharma

Therapeutic Areas

Alzheimer's DiseaseCognitive DisordersNeuropathic PainOsteoarthritis Pain

AlzeCure Pharma Pipeline

DrugIndicationPhase
NeuroRestore ACD856Alzheimer's Disease (Cognitive Symptoms)Phase 2
Alzstatin ProgramAlzheimer's Disease (Disease Modification)Pre-clinical
Painless ACD440Neuropathic Pain / ErythromelalgiaPhase 2
Painless TrkA-NAMSevere Pain (e.g., Osteoarthritis)Pre-clinical

Leadership Team at AlzeCure Pharma

MJ
Martin Jönsson
Chief Executive Officer (CEO)
JS
Johan Sandin
Chief Scientific Officer (CSO)
View full AlzeCure Pharma profile